MedPath

Solventum US LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

65

Active:0
Completed:44

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:4
Phase 2:4
+3 more phases

Drug Approvals

4

FDA:4

Drug Approvals

Clinpro 5000

Approval Date
Apr 1, 2024
FDA

Clinpro 5000

Approval Date
Apr 1, 2024
FDA

Clinpro 5000

Approval Date
Apr 1, 2024
FDA

Peridex

Approval Date
Apr 1, 2024
FDA

Clinical Trials

Distribution across different clinical trial phases (49 trials with phase data)• Click on a phase to view related trials

Not Applicable
33 (67.3%)
Phase 1
4 (8.2%)
Phase 2
4 (8.2%)
Phase 4
4 (8.2%)
Phase 3
3 (6.1%)
Early Phase 1
1 (2.0%)

A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing

Not Applicable
Recruiting
Conditions
Wound
First Posted Date
2024-10-03
Last Posted Date
2025-07-23
Lead Sponsor
Solventum US LLC
Target Recruit Count
90
Registration Number
NCT06625385
Locations
🇺🇸

IU Health Methodist Hospital, Indianapolis, Indiana, United States

🇺🇸

Washington University - Barnes Jewish Hospital, Saint Louis, Missouri, United States

🇺🇸

St. Luke's University Hospital, Bethlehem, Pennsylvania, United States

[Trial of device that is not approved or cleared by the U.S. FDA]

Not Applicable
First Posted Date
2024-01-22
Last Posted Date
2025-05-06
Lead Sponsor
[Redacted]
Target Recruit Count
452
Registration Number
NCT06217081

A Comparison Study of Hypersensitivity Treatment

Not Applicable
Completed
Conditions
Dentin Hypersensitivity
First Posted Date
2023-03-14
Last Posted Date
2025-02-07
Lead Sponsor
Solventum US LLC
Target Recruit Count
101
Registration Number
NCT05768373
Locations
🇺🇸

LOMA LINDA UNIVERSITY, School of Dentistry, Loma Linda, California, United States

3M Veraflo™ Cleanse Choice Complete™ (VFCCC) Clinical Study

Not Applicable
Withdrawn
Conditions
WOUNDS INJURIES
First Posted Date
2023-02-28
Last Posted Date
2024-10-01
Lead Sponsor
Solventum US LLC
Registration Number
NCT05748392
Locations
🇺🇸

3M, Saint Paul, Minnesota, United States

Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy

Not Applicable
Terminated
Conditions
Central Venous Catheter Exit Site Infection
Catheter-Related Infections
First Posted Date
2021-05-28
Last Posted Date
2024-10-16
Lead Sponsor
Solventum US LLC
Target Recruit Count
123
Registration Number
NCT04906512
Locations
🇨🇳

Ruijin Hospital, Shanghai, Shanghai, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.